{
  "id": [
    "26553686"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "26553686"
  ],
  "pmcid": [
    "PMC4639492"
  ],
  "doi": [
    "10.1093/cid/civ519"
  ],
  "title": [
    "Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso."
  ],
  "authorString": [
    "Tall H, Yaro S, Kpoda HB, Ouangraoua S, Trotter CL, Njanpop Lafourcade BM, Findlow H, Bai X, Martin C, Nwakamma I, Ouedraogo JB, Gessner BD, Borrow R, Mueller JE."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Tall H"
          ],
          "firstName": [
            "Haoua"
          ],
          "lastName": [
            "Tall"
          ],
          "initials": [
            "H"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Agence de Médecine Préventive, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Yaro S"
          ],
          "firstName": [
            "Seydou"
          ],
          "lastName": [
            "Yaro"
          ],
          "initials": [
            "S"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre Muraz, Bobo-Dioulasso, Burkina Faso."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Kpoda HB"
          ],
          "firstName": [
            "Hervé B N"
          ],
          "lastName": [
            "Kpoda"
          ],
          "initials": [
            "HB"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre Muraz, Bobo-Dioulasso, Burkina Faso."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Ouangraoua S"
          ],
          "firstName": [
            "Soumeya"
          ],
          "lastName": [
            "Ouangraoua"
          ],
          "initials": [
            "S"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Centre Muraz, Bobo-Dioulasso, Burkina Faso."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Trotter CL"
          ],
          "firstName": [
            "Caroline L"
          ],
          "lastName": [
            "Trotter"
          ],
          "initials": [
            "CL"
          ],
          "authorId": [
            {
              "_": "0000-0003-4000-2708",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Disease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Njanpop Lafourcade BM"
          ],
          "firstName": [
            "Berthe-Marie"
          ],
          "lastName": [
            "Njanpop Lafourcade"
          ],
          "initials": [
            "BM"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Agence de Médecine Préventive, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Findlow H"
          ],
          "firstName": [
            "Helen"
          ],
          "lastName": [
            "Findlow"
          ],
          "initials": [
            "H"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, United Kingdom."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Bai X"
          ],
          "firstName": [
            "Xilian"
          ],
          "lastName": [
            "Bai"
          ],
          "initials": [
            "X"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, United Kingdom."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Martin C"
          ],
          "firstName": [
            "Catherine"
          ],
          "lastName": [
            "Martin"
          ],
          "initials": [
            "C"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Agence de Médecine Préventive, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Nwakamma I"
          ],
          "firstName": [
            "Ikenna"
          ],
          "lastName": [
            "Nwakamma"
          ],
          "initials": [
            "I"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Ecole des Hautes Etudes en Santé Publique French School of Public Health, Sorbonne Paris Cité, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Ouedraogo JB"
          ],
          "firstName": [
            "Jean Bosco"
          ],
          "lastName": [
            "Ouedraogo"
          ],
          "initials": [
            "JB"
          ],
          "authorId": [
            {
              "_": "0000-0003-0412-8733",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Institut de Recherche en Science et Santé, Bobo-Dioulasso, Burkina Faso."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Gessner BD"
          ],
          "firstName": [
            "Bradford D"
          ],
          "lastName": [
            "Gessner"
          ],
          "initials": [
            "BD"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Agence de Médecine Préventive, Paris, France."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Borrow R"
          ],
          "firstName": [
            "Ray"
          ],
          "lastName": [
            "Borrow"
          ],
          "initials": [
            "R"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, United Kingdom."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Mueller JE"
          ],
          "firstName": [
            "Judith E"
          ],
          "lastName": [
            "Mueller"
          ],
          "initials": [
            "JE"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Ecole des Hautes Etudes en Santé Publique French School of Public Health, Sorbonne Paris Cité, France Institut Pasteur, Paris, France."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0003-4000-2708",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0003-0412-8733",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "volume": [
        "61 Suppl 5"
      ],
      "journalIssueId": [
        "2342122"
      ],
      "dateOfPublication": [
        "2015 Nov"
      ],
      "monthOfPublication": [
        "11"
      ],
      "yearOfPublication": [
        "2015"
      ],
      "printPublicationDate": [
        "2015-11-01"
      ],
      "journal": [
        {
          "title": [
            "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"
          ],
          "ISOAbbreviation": [
            "Clin. Infect. Dis."
          ],
          "medlineAbbreviation": [
            "Clin Infect Dis"
          ],
          "NLMid": [
            "9203213"
          ],
          "ISSN": [
            "1058-4838"
          ],
          "ESSN": [
            "1537-6591"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2015"
  ],
  "pageInfo": [
    "S540-6"
  ],
  "abstractText": [
    "A group A meningococcal (MenA) conjugate vaccine, PsA-TT (MenAfriVac), was introduced in Burkina Faso via mass campaigns between September and December 2010, targeting the 1- to 29-year-old population. This study describes specific antibody titers in the general population 11 months later and compares them to preintroduction data obtained during 2008 using the same protocol.During October-November 2011, we recruited a representative sample of the population of urban Bobo-Dioulasso aged 6 months to 29 years, who underwent standardized interviews and blood draws. We assessed anti-MenA immunoglobulin G (IgG) concentrations (n = 200) and, using rabbit complement, serum bactericidal antibody (SBA) titers against 2 group A strains: reference strain F8238 (SBAref) (n = 562) and strain 3125 (SBA3125) (n = 200).Among the 562 participants, 481 (86%) were aged ≥23 months and had been eligible for the PsA-TT campaign. Among them, vaccine coverage was 86.3% (95% confidence interval [CI], 82.7%-89.9%). Prevalence of putatively protective antibodies among vaccine-eligible age groups was 97.3% (95% CI, 95.9%-98.7%) for SBAref titers ≥128, 83.6% (95% CI, 77.6%-89.7%) for SBA3125 ≥128, and 84.2% (95% CI, 78.7%-89.7%) for anti-MenA IgG ≥2 µg/mL. Compared to the population aged 23 months to 29 years during 2008, geometric mean titers of SBAref were 7.59-fold higher during 2011, 51.88-fold for SBA3125, and 10.56-fold for IgG.This study shows high seroprevalence against group A meningococci in Burkina Faso following MenAfriVac introduction. Follow-up surveys will provide evidence on the persistence of population-level immunity and the optimal vaccination strategy for long-term control of MenA meningitis in the African meningitis belt."
  ],
  "affiliation": [
    "Agence de Médecine Préventive, Paris, France."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Research Support, Non-U.S. Gov't",
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Animals"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Rabbits"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neisseria meningitidis, Serogroup A"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Meningitis, Meningococcal"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PC"
                  ],
                  "qualifierName": [
                    "prevention & control"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunoglobulin G"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Meningococcal Vaccines"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AD"
                  ],
                  "qualifierName": [
                    "administration & dosage"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Bacterial"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Seroepidemiologic Studies"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Blood Bactericidal Activity"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adolescent"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Child"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Child, Preschool"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Infant"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Burkina Faso"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Complement System Proteins"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Young Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Mass Vaccination"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Sub-Saharan Africa",
        "Neisseria meningitidis",
        "Seroepidemiologic Studies",
        "conjugate",
        "Group A"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Immunoglobulin G"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Antibodies, Bacterial"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Meningococcal Vaccines"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Complement System Proteins"
          ],
          "registryNumber": [
            "9007-36-7"
          ]
        },
        {
          "name": [
            "MenAfriVac"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1093/cid/civ519"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC4639492"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC4639492?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1093/cid/civ519"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "6"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "N"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2016-08-30"
  ],
  "dateOfCreation": [
    "2015-11-10"
  ],
  "firstIndexDate": [
    "2015-11-11"
  ],
  "fullTextReceivedDate": [
    "2015-11-15"
  ],
  "dateOfRevision": [
    "2015-11-13"
  ],
  "firstPublicationDate": [
    "2015-11-01"
  ]
}